D-0646-2020 Class II Terminated
FDA drug recall D-0646-2020 was initiated by AAA Pharmaceutical, Inc. on Dec 26, 2019 and is designated Class II. Reason for recall: CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API The recall status is terminated (terminated Mar 10, 2021). Affected quantity: 31,536 (130-count bottles).
Recall details
- Product Type
- Drugs
- Report Date
- Jan 15, 2020
- Initiation Date
- Dec 26, 2019
- Termination Date
- Mar 10, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 31,536 (130-count bottles)
Product description
Reason for recall
Distribution pattern
Product was distributed to one consignee who may have distributed the product further to their retail stores.
Code information
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0646-2020
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for AAA Pharmaceutical, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.